Inventor · disambiguated record
Jack Tzu-Chiao Lin
Also filed as: LIN JACK T · LIN JACK TZU CHIAO
5 granted patents·8 pending applications·15 citations·filing 2010–2022
74Inventor score
Files withSENTI BIOSCIENCES INC7TEVA PHARMACEUTICALS AUSTRALIA PTY LTD3ANVIL BIOSCIENCES LLC1GARRISON FATHMAN C1SENTI BIOSCIENCE INC1
Top patents by PatentIndex Score
13 records- 0187US10993967B2Combinatorial cancer immunotherapySENTI BIOSCIENCES INC·Filed 2019·Granted May 4, 2021·5 cites·31 claims
- 0287US9611322B2Fusions of antibodies to CD38 and attenuated interferon alphaTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2014·Granted Apr 4, 2017·6 cites·18 claims
- 0385US11419898B2Combinatorial cancer immunotherapySENTI BIOSCIENCES INC·Filed 2021·Granted Aug 23, 2022·2 cites·20 claims
- 0483US10981986B2Fusions of antibodies to CD38 and attenuated interferon alphaTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2017·Granted Apr 20, 2021·2 cites·21 claims
- 0565US2022378842A1Combinatorial cancer immunotherapySENTI BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 0664US2023270789A1Combinatorial cancer immunotherapySENTI BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 0759US11446332B2Combinatorial cancer immunotherapySENTI BIOSCIENCES INC·Filed 2018·Granted Sep 20, 2022·0 cites·18 claims
- 0857US2023011052A1Method and compositions for regulated armoring of cellsSENTI BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 0954US2016367695A1Polypeptide constructs and uses thereofTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2016·Application pending·0 cites
- 1051US2022378822A1Combinatorial cancer immunotherapySENTI BIOSCIENCE INC·Filed 2020·Application pending·0 cites
- 1144US2020085876A1Immunomodulating cell circuitsSENTI BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 1239US2018050082A1Serpins for the treatment of neuroinflammatory diseasesANVIL BIOSCIENCES LLC·Filed 2016·Application pending·0 cites
- 1332US2010297123A1Combination therapy to inhibit t cell effector functionGARRISON FATHMAN C·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →